The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

BIOX Corp closed at $0.95.

Over the last five days, shares have gained 7.95% and 187.88% year to date. Shares have outperformed the S&P TSX by 57.41% during the last year.

Key company metrics

  • Trailing P/E88.21×
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS$0.01
Updated September 4 3:02 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.87%Sector:EnergyIndustry:Oil & Gas Refining & Marketing
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Fiscal Quarter Endvalues in $ millions unless otherwise notedMar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014
Total other revenue--------
Total revenue16271817
Gross profit-16-1-2
Total cost of revenue17211918
Total operating expense18232020
Selling / general / administrative1111
Research & development0--00
Depreciation / amortization0000
Interest expense (income), net operating--------
Unusual expense (income)0--00
Other operating expenses, total--------
Operating income-25-2-3
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Income before tax-24-3-3
Income after tax-241-3
Income tax, total00-40
Net income-241-3
Total adjustments to net income--------
Net income before extra. items-241-3
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-241-3
Inc. avail. to common incl. extra. items-241-3
Diluted net income-241-3
Dilution adjustment0----0
Diluted weighted average shares46464646
Diluted EPS excluding extraordinary itemsvalue per share-
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share-